Bone and Joint Infections

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: INfectious DIsease REgistry BIObank

  This entry (NCT06418048) for the Infectious Disease Registry Biobank indicates the study is currently recruiting, sponsored by IRCCS San Raf…

• CLINICAL_TRIALS trial_result · 2020-01-30
  Clinical Trial Update: Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections [Phase 2, Phase 3]

  Phase 2/3 trial update for oral sodium fusidate (CEM-102) in refractory bone or joint infections has completed, with results posted in 2020.

• FDA approval · 2019-08-20
  FDA Approved: CLINDAMYCIN HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for clindamycin hydrochloride from Chartwell RX, LLC.

• FDA approval · 2016-06-29
  FDA Approved: CEFTRIAXONE SODIUM — Original Application (Qilu Pharmaceutical Co., Ltd.)

  FDA approved the Original Application for ceftriaxone sodium from Qilu Pharmaceutical Co., Ltd., a broad-spectrum cephalosporin used to trea…

• FDA approval · 2016-03-31
  FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Eugia US LLC)

  The FDA approved a generic vancomycin hydrochloride for injection under an original application from Eugia US LLC. This adds a generic IV op…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2015-06-18
  Clinical Trial Update: Clinical Evaluation of Daptomycin Bone Penetration

  This entry covers a clinical trial evaluating the bone penetration of daptomycin in bone and joint infections. The current status is unknown…

• FDA approval · 2011-09-30
  FDA Approved: CLINDAMYCIN — Original Application (Sagent Pharmaceuticals)

  FDA approved Sagent Pharmaceuticals' original application for CLINDAMYCIN PHOSPHATE (clindamycin), a generic antibiotic for treating suscept…